CDEK
← All organizations

Innoviva

For profitContributed to NME

Also known as: Innoviva Specialty Therapeutics

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 4

First clinical trial

Mar 31, 2025

First marketed drug

May 23, 2023

First NDA

May 23, 2023

Last known activity

Dec 12, 2025

Timeline

1990s

  1. Jun 1, 1996

    Innoviva— Founded

2020s

  1. May 23, 2022

    Entasis Therapeutics— Acquired

  2. May 23, 2023

    sulbactam— NDA Secondary Org

  3. May 23, 2023

    durlobactam— NDA Organization

Drugs by trial phase (11 distinct, 11 trials)

Phase 4 (1 own, 0 via acquisition)

Phase 3 (0 own, 5 via acquisition)

Phase 2 (1 own, 0 via acquisition)

Phase 1 (0 own, 4 via acquisition)

Marketed drugs (2)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (2)

Details

Founded
South San Francisco, CA, US Jun 1, 1996
First NDA
May 23, 2023
Last known activity
Dec 12, 2025

Designations held

  • Fast track
  • Priority review